Utah Medical Products, Inc. (UTMD) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Utah Medical Products, Inc. (UTMD) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

UTMD Income Statement

Utah Medical Products, Inc. (UTMD) annual income statement — 30-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	8.62M	8.53M	8.72M	9.04M	9.81M	9.95M	9.71M	9.16M	10.01M	10.4M	11.34M	12.33M	12.51M	12.87M	12.52M	13.57M	12.96M	13.43M	12.32M	12.91M
Revenue Growth %	-12.14%	-14.31%	-10.18%	-1.23%	-1.93%	-4.3%	-14.37%	-25.74%	-19.99%	-19.17%	-9.42%	-9.14%	-3.47%	-4.19%	1.6%	5.11%	3.05%	6.54%	12.4%	7.53%
Cost of Goods Sold	3.78M	3.77M	3.44M	3.78M	4.21M	4.36M	4.17M	3.83M	4.2M	4.15M	4.57M	5.24M	6.76M	6.74M	4.68M	5.25M	4.77M	5.28M	4.79M	4.8M
COGS % of Revenue	43.86%	44.21%	39.44%	41.8%	42.89%	43.79%	42.97%	41.88%	42.01%	39.88%	40.34%	42.45%	54.08%	52.37%	37.36%	38.65%	36.81%	39.3%	38.87%	37.18%
Gross Profit	4.84M	4.76M	5.28M	5.26M	5.6M	5.59M	5.54M	5.32M	5.8M	6.25M	6.77M	7.1M	5.74M	6.13M	7.84M	8.33M	8.19M	8.15M	7.53M	8.11M
Gross Margin %	56.14%	55.79%	60.56%	58.2%	57.11%	56.21%	57.03%	58.12%	57.99%	60.12%	59.66%	57.55%	45.92%	47.63%	62.64%	61.35%	63.19%	60.7%	61.13%	62.82%
Gross Profit Growth %	-13.63%	-14.96%	-4.62%	-1.11%	-3.41%	-10.52%	-18.15%	-25.01%	1.04%	2.04%	-13.73%	-14.76%	-29.86%	-24.82%	4.12%	2.64%	1.4%	4.7%	42.59%	11.67%
Operating Expenses	2.04M	2.11M	2.72M	2.82M	2.99M	2.4M	2.38M	2.39M	2.46M	2.81M	2.88M	3.15M	1.77M	1.7M	3.4M	3.26M	3.04M	3.09M	3.01M	2.98M
OpEx % of Revenue	23.72%	24.73%	31.15%	31.21%	30.5%	24.1%	24.56%	26.13%	24.58%	27.07%	25.42%	25.57%	14.18%	13.24%	27.19%	23.99%	23.5%	23.04%	24.43%	23.1%
Selling, General & Admin	1.9M	1.96M	2.56M	2.61M	2.83M	2.26M	1.42M	7.6M	2.29M	2.56M	1.36M	11.04M	1.64M	1.57M	1.26M	11.24M	2.93M	2.96M	2.89M	11.49M
SG&A % of Revenue	22.07%	22.92%	29.39%	28.87%	28.8%	22.75%	14.57%	82.95%	22.86%	24.62%	12.01%	89.52%	13.07%	12.2%	10.09%	82.83%	22.64%	22.04%	23.44%	88.97%
Research & Development	142K	154K	154K	212K	167K	135K	155K	121K	172K	255K	266K	146K	138K	133K	144K	123K	112K	135K	123K	141K
R&D % of Revenue	1.65%	1.81%	1.77%	2.34%	1.7%	1.36%	1.6%	1.32%	1.72%	2.45%	2.35%	1.18%	1.1%	1.03%	1.15%	0.91%	0.86%	1.01%	1%	1.09%
Other Operating Expenses	0	0	0	0	0	0	815K	-1000K	0	0	1000K	-1000K	0	0	1000K	-1000K	0	0	8K	-1000K
Operating Income	2.79M	2.65M	2.56M	2.44M	2.61M	3.2M	3.15M	2.93M	3.34M	3.44M	3.88M	3.94M	3.97M	4.42M	4.44M	5.07M	5.14M	5.06M	4.52M	5.13M
Operating Margin %	32.42%	31.06%	29.41%	26.99%	26.61%	32.11%	32.47%	31.99%	33.41%	33.06%	34.24%	31.98%	31.74%	34.39%	35.46%	37.35%	39.68%	37.66%	36.7%	39.72%
Operating Income Growth %	7.05%	-17.12%	-18.65%	-16.69%	-21.9%	-7.04%	-18.8%	-25.71%	-15.77%	-22.31%	-12.53%	-22.21%	-22.8%	-12.5%	-1.84%	-1.17%	0.84%	6.13%	16.31%	19.86%
EBITDA	3.05M	2.88M	3.24M	3.19M	3.36M	3.94M	3.87M	3.66M	4.07M	4.12M	4.57M	4.97M	5.75M	6.2M	6.2M	6.81M	6.89M	6.83M	6.33M	6.93M
EBITDA Margin %	35.37%	33.71%	37.12%	35.22%	34.28%	39.6%	39.9%	39.97%	40.69%	39.61%	40.26%	40.3%	46.01%	48.22%	49.54%	50.15%	53.15%	50.89%	51.38%	53.68%
EBITDA Growth %	-9.36%	-27.05%	-16.42%	-12.95%	-17.37%	-4.32%	-15.16%	-26.36%	-29.25%	-33.61%	-26.39%	-27%	-16.44%	-9.21%	-2.02%	-1.79%	-0.61%	3.39%	10.59%	14.01%
D&A (Non-Cash Add-back)	254K	226K	673K	745K	753K	745K	721K	730K	728K	681K	683K	1.03M	1.78M	1.78M	1.76M	1.74M	1.75M	1.78M	1.81M	1.8M
EBIT	3.4M	3.29M	3.18M	3.11M	3.31M	3.84M	3.47M	3.27M	4.18M	4.21M	4.63M	4.6M	4.78M	5.17M	4.85M	5.74M	5.34M	5.2M	4.53M	5.15M
Net Interest Income	0	0	631K	0	719K	679K	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Income	0	0	631K	0	719K	679K	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	606K	637K	617K	665K	698K	640K	705K	684K	836K	773K	915K	1.07M	812K	747K	680K	521K	198K	142K	8K	51K
Pretax Income	3.4M	3.29M	3.18M	3.11M	3.31M	3.84M	3.86M	3.61M	4.18M	4.21M	4.8M	5.02M	4.78M	5.17M	5.12M	5.59M	5.34M	5.2M	4.53M	5.18M
Pretax Margin %	39.45%	38.53%	36.48%	34.34%	33.72%	38.54%	39.73%	39.46%	41.77%	40.49%	42.31%	40.68%	38.23%	40.2%	40.89%	41.19%	41.21%	38.72%	36.76%	40.12%
Income Tax	614K	600K	578K	540K	678K	788K	817K	712K	616K	758K	842K	731K	846K	972K	905K	1.04M	1.06M	1.1M	996K	1.05M
Effective Tax Rate %	18.05%	18.26%	18.16%	17.39%	20.49%	20.54%	21.18%	19.7%	14.74%	18%	17.55%	14.57%	17.7%	18.79%	17.68%	18.53%	19.84%	21.08%	21.99%	20.25%
Net Income	2.79M	2.69M	2.6M	2.57M	2.63M	3.05M	3.04M	2.9M	3.56M	3.45M	3.96M	4.29M	3.94M	4.2M	4.21M	4.55M	4.28M	4.1M	3.53M	4.13M
Net Margin %	32.33%	31.49%	29.86%	28.37%	26.81%	30.62%	31.32%	31.69%	35.61%	33.2%	34.89%	34.75%	31.47%	32.64%	33.66%	33.56%	33.04%	30.56%	28.68%	32%
Net Income Growth %	5.93%	-11.88%	-14.37%	-11.58%	-26.16%	-11.73%	-23.13%	-32.29%	-9.45%	-17.79%	-6.12%	-5.91%	-8.06%	2.36%	19.24%	10.24%	1.76%	19.76%	16.87%	21.1%
Net Income (Continuing)	2.79M	2.69M	2.6M	2.57M	2.63M	3.05M	3.04M	2.9M	3.56M	3.45M	3.96M	4.29M	3.94M	4.2M	4.21M	4.55M	4.28M	4.1M	3.53M	4.13M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.88	0.84	0.82	0.80	0.82	0.94	0.92	0.86	1.02	0.98	1.09	1.18	1.08	1.15	1.16	1.25	1.18	1.12	0.96	1.13
EPS Growth %	7.32%	-10.64%	-10.87%	-6.74%	-19.61%	-4.08%	-15.6%	-27.12%	-5.56%	-14.78%	-6.03%	-5.6%	-8.47%	2.68%	20.83%	10.62%	2.61%	19.15%	15.66%	21.51%
EPS (Basic)	0.88	0.84	0.82	0.80	0.82	0.94	0.92	0.86	1.02	0.98	1.09	1.18	1.08	1.16	1.16	1.26	1.18	1.13	0.97	1.13
Diluted Shares Outstanding	3.18M	3.18M	3.19M	3.2M	3.21M	3.25M	3.31M	3.39M	3.48M	3.53M	3.62M	3.63M	3.64M	3.64M	3.64M	3.63M	3.63M	3.65M	3.67M	3.67M
Basic Shares Outstanding	3.18M	3.18M	3.19M	3.2M	3.21M	3.25M	3.31M	3.39M	3.48M	3.53M	3.62M	3.63M	3.63M	3.63M	3.63M	3.63M	3.63M	3.64M	3.65M	3.65M
Dividend Payout Ratio	-	36.75%	37.98%	38.07%	37.55%	32.84%	33.44%	35.77%	29.53%	31.31%	27.53%	24.99%	27.22%	25.48%	25.39%	23.07%	24.58%	25.83%	-	202.06%